
Phuong N. Huynh
Examiner (ID: 3827, Phone: (571)272-0846 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1641, 1644 |
| Total Applications | 2195 |
| Issued Applications | 1131 |
| Pending Applications | 251 |
| Abandoned Applications | 828 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7285837
[patent_doc_number] => 20040146502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Use of organic compounds'
[patent_app_type] => new
[patent_app_number] => 10/476509
[patent_app_country] => US
[patent_app_date] => 2004-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 858
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146502.pdf
[firstpage_image] =>[orig_patent_app_number] => 10476509
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/476509 | Use of organic compounds | Mar 16, 2004 | Abandoned |
Array
(
[id] => 7034523
[patent_doc_number] => 20050033033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Trans-membrane-antibody induced inhibition of apoptosis'
[patent_app_type] => utility
[patent_app_number] => 10/795081
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12277
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20050033033.pdf
[firstpage_image] =>[orig_patent_app_number] => 10795081
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/795081 | Trans-membrane-antibody induced inhibition of apoptosis | Mar 4, 2004 | Abandoned |
Array
(
[id] => 6972523
[patent_doc_number] => 20050038233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use'
[patent_app_type] => utility
[patent_app_number] => 10/792311
[patent_app_country] => US
[patent_app_date] => 2004-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11426
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20050038233.pdf
[firstpage_image] =>[orig_patent_app_number] => 10792311
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/792311 | Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use | Mar 1, 2004 | Issued |
Array
(
[id] => 7341564
[patent_doc_number] => 20040191268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Ha-1 antigen'
[patent_app_type] => new
[patent_app_number] => 10/791217
[patent_app_country] => US
[patent_app_date] => 2004-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12461
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20040191268.pdf
[firstpage_image] =>[orig_patent_app_number] => 10791217
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/791217 | HA-1 antigen | Mar 1, 2004 | Issued |
Array
(
[id] => 7428374
[patent_doc_number] => 20040161802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Methods for producing and improving therapeutic potency of binding polypeptides'
[patent_app_type] => new
[patent_app_number] => 10/788940
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19296
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20040161802.pdf
[firstpage_image] =>[orig_patent_app_number] => 10788940
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/788940 | Methods for producing and improving therapeutic potency of binding polypeptides | Feb 25, 2004 | Abandoned |
Array
(
[id] => 7307283
[patent_doc_number] => 20040141917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Antibodies to truncated VEGF-D and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/779731
[patent_app_country] => US
[patent_app_date] => 2004-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8523
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20040141917.pdf
[firstpage_image] =>[orig_patent_app_number] => 10779731
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/779731 | Antibodies to truncated VEGF-D and uses thereof | Feb 17, 2004 | Issued |
Array
(
[id] => 7348114
[patent_doc_number] => 20040192898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Anti-abeta antibodies'
[patent_app_type] => new
[patent_app_number] => 10/487322
[patent_app_country] => US
[patent_app_date] => 2004-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14101
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192898.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487322
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487322 | Anti-abeta antibodies | Feb 16, 2004 | Abandoned |
Array
(
[id] => 7252121
[patent_doc_number] => 20040259156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Bispecific immunoglobulin-like antigen binding proteins and method of production'
[patent_app_type] => new
[patent_app_number] => 10/778910
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15844
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259156.pdf
[firstpage_image] =>[orig_patent_app_number] => 10778910
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/778910 | Bispecific immunoglobulin-like antigen binding proteins and method of production | Feb 12, 2004 | Abandoned |
Array
(
[id] => 7230009
[patent_doc_number] => 20040156821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'System for controlling immune system response to antigen'
[patent_app_type] => new
[patent_app_number] => 10/775460
[patent_app_country] => US
[patent_app_date] => 2004-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12998
[patent_no_of_claims] => 281
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20040156821.pdf
[firstpage_image] =>[orig_patent_app_number] => 10775460
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/775460 | System for controlling immune system response to antigen | Feb 9, 2004 | Abandoned |
Array
(
[id] => 5661048
[patent_doc_number] => 20060251644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'High affinity anti-human ige antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/544056
[patent_app_country] => US
[patent_app_date] => 2004-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 18301
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20060251644.pdf
[firstpage_image] =>[orig_patent_app_number] => 10544056
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/544056 | High affinity anti-human IgE antibodies | Feb 1, 2004 | Issued |
Array
(
[id] => 7261349
[patent_doc_number] => 20040241158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Methods and compositions for administering therapeutic and diagnostic agents'
[patent_app_type] => new
[patent_app_number] => 10/768707
[patent_app_country] => US
[patent_app_date] => 2004-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 34787
[patent_no_of_claims] => 151
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241158.pdf
[firstpage_image] =>[orig_patent_app_number] => 10768707
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/768707 | Methods and compositions for administering therapeutic and diagnostic agents | Feb 1, 2004 | Issued |
Array
(
[id] => 5851105
[patent_doc_number] => 20060234296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Method for generating high affinity antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/544057
[patent_app_country] => US
[patent_app_date] => 2004-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 17850
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234296.pdf
[firstpage_image] =>[orig_patent_app_number] => 10544057
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/544057 | Method for generating high affinity antibodies | Feb 1, 2004 | Abandoned |
Array
(
[id] => 7310364
[patent_doc_number] => 20040142869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Methods of use of recombinant vasoactive protein from salivary gland of the black fly'
[patent_app_type] => new
[patent_app_number] => 10/768874
[patent_app_country] => US
[patent_app_date] => 2004-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4405
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142869.pdf
[firstpage_image] =>[orig_patent_app_number] => 10768874
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/768874 | Methods of use of recombinant vasoactive protein from salivary gland of the black fly | Jan 29, 2004 | Abandoned |
Array
(
[id] => 7304577
[patent_doc_number] => 20040115835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Methods for predicting impaired performance in equines'
[patent_app_type] => new
[patent_app_number] => 10/363297
[patent_app_country] => US
[patent_app_date] => 2004-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4734
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20040115835.pdf
[firstpage_image] =>[orig_patent_app_number] => 10363297
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/363297 | Methods for predicting impaired performance in equines | Jan 28, 2004 | Abandoned |
Array
(
[id] => 7295022
[patent_doc_number] => 20040213797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Conjugates for the modulation of immune responses'
[patent_app_type] => new
[patent_app_number] => 10/763362
[patent_app_country] => US
[patent_app_date] => 2004-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 26065
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20040213797.pdf
[firstpage_image] =>[orig_patent_app_number] => 10763362
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/763362 | Conjugates for the modulation of immune responses | Jan 22, 2004 | Abandoned |
Array
(
[id] => 7422528
[patent_doc_number] => 20040229310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture'
[patent_app_type] => new
[patent_app_number] => 10/764428
[patent_app_country] => US
[patent_app_date] => 2004-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 40264
[patent_no_of_claims] => 128
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229310.pdf
[firstpage_image] =>[orig_patent_app_number] => 10764428
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/764428 | Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture | Jan 22, 2004 | Issued |
Array
(
[id] => 612627
[patent_doc_number] => 07148023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-12
[patent_title] => 'Immunoglobulin E detection in mammalian species'
[patent_app_type] => utility
[patent_app_number] => 10/758165
[patent_app_country] => US
[patent_app_date] => 2004-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3270
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/148/07148023.pdf
[firstpage_image] =>[orig_patent_app_number] => 10758165
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/758165 | Immunoglobulin E detection in mammalian species | Jan 14, 2004 | Issued |
Array
(
[id] => 466062
[patent_doc_number] => 07235241
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-06-26
[patent_title] => 'Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone'
[patent_app_type] => utility
[patent_app_number] => 10/751451
[patent_app_country] => US
[patent_app_date] => 2004-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4226
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/235/07235241.pdf
[firstpage_image] =>[orig_patent_app_number] => 10751451
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/751451 | Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone | Jan 5, 2004 | Issued |
Array
(
[id] => 7449828
[patent_doc_number] => 20040186274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Methylation of histone h4 at arginine 3'
[patent_app_type] => new
[patent_app_number] => 10/482725
[patent_app_country] => US
[patent_app_date] => 2004-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13283
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20040186274.pdf
[firstpage_image] =>[orig_patent_app_number] => 10482725
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/482725 | Methylation of histone h4 at arginine 3 | Jan 1, 2004 | Abandoned |
Array
(
[id] => 303291
[patent_doc_number] => 07534427
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-19
[patent_title] => 'Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins'
[patent_app_type] => utility
[patent_app_number] => 10/747199
[patent_app_country] => US
[patent_app_date] => 2003-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13200
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534427.pdf
[firstpage_image] =>[orig_patent_app_number] => 10747199
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/747199 | Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins | Dec 29, 2003 | Issued |